Olaf Penak

49PUBLICATIONS
301CO-AUTHORS
HaematologyCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesAutoimmunityGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Aug 31, 2026
Tisagenlecleucel for post-transplant relapse in young acute lymphoblastic leukemia patients: European real-world determinants of outcome.

|Aug 27, 2026
CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial.

|Aug 19, 2026
Fecal microbiota transplantation in the treatment of acute graft-versus-host disease: A retrospective study performed by the Complications Working Party and Pediatric Diseases Working Party of the EBMT.

|Jul 27, 2026
Secondary autoimmune and inflammatory diseases after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT transplant complications and autoimmune diseases working parties.

|May 27, 2026
The 2024 EBMT activity report: crossing one million HCTs and 20,000 CAR-T. A landmark in cellular therapy.

|May 13, 2026
Central nervous system complications after allogeneic haematopoietic cell transplantation: best practice recommendations from the EBMT practice harmonisation and guidelines committee on epidemiology, outcome and neuroimaging.

Pageof 9

Frequent Collaborators

23 joint publications

Hélène Schoemans

15 joint publications

Koenecke Ch

14 joint publications

Zinaida Peric

13 joint publications

Ivan Moiseev